1. Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development – (III) A Randomized Trial with Interferon Beta‐1a Products. Issue 2 (2nd December 2022) Authors: Florian, Jeffry; Gershuny, Victoria; Sun, Qin; Schrieber, Sarah J.; Matta, Murali K.; Hazel, Anthony; Sheikhy, Morasa; Weaver, James L.; Hyland, Paula L.; Hsiao, Cheng‐Hui; Vegesna, Giri; DePalma, Ryan; Shah, Aanchal; Prentice, Kristin; Sanabria, Carlos; Wang, Yow‐Ming; Strauss, David G. Journal: Clinical pharmacology & therapeutics Issue: Volume 113:Issue 2(2023) Page Start: 339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗